Entrada Therapeutics (TRDA)
(Delayed Data from NSDQ)
$14.72 USD
-0.31 (-2.06%)
Updated Sep 10, 2024 04:00 PM ET
After-Market: $14.70 -0.02 (-0.14%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth A Momentum C VGM
Earnings News For TRDA
-
Entrada Therapeutics, Inc. (TRDA) Tops Q2 Earnings and Revenue Estimates
-
Entrada Therapeutics Reports Second Quarter 2024 Financial Results
-
Entrada Therapeutics Reports First Quarter 2024 Financial Results
-
Entrada Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
-
Entrada Therapeutics, Inc. (TRDA) Surpasses Q3 Earnings and Revenue Estimates
-
Entrada Therapeutics Reports Third Quarter 2023 Financial Results
-
Entrada Therapeutics, Inc. (TRDA) Reports Q2 Loss, Misses Revenue Estimates
-
Entrada Therapeutics Reports Second Quarter 2023 Financial Results
-
Entrada Therapeutics Reports First Quarter 2023 Financial Results
-
Entrada Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
-
Entrada Therapeutics Reports Third Quarter 2022 Financial Results